A year ago, they were trading at $2.66. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
On Tuesday, Rigel Pharmaceuticals (NASDAQ: RIGL) will release its latest earnings report ... Analysts have been rating Rigel Pharmaceuticals stock as Neutral. The strength of this rating has maintained conviction over the past three months.